Literature DB >> 24357176

[Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein].

N Eisemann1, A Waldmann, A Katalinic.   

Abstract

A pilot project in skin cancer screening (SCREEN) was conducted in Schleswig-Holstein from July 2003 to June 2004. Although the impact of this screening on the stage-specific incidence of melanoma is of great importance for screening evaluation, it remains unknown. In theory, an effective skin cancer screening program should result in a medium-term incidence decrease of melanomas with a prognostically unfavorable stage. This is studied on a population-based level by using cancer registry data. Based on data from the Cancer Registry of Schleswig-Holstein for 1999-2009, stage-specific (T-category of the TNM-classification system) age-standardized incidence rates were calculated. After implementation of the SCREEN project, the incidence of prognostically favorable melanomas (in situ and T1) was higher than before, while the incidence of advanced melanomas (T2, T3, and for women also T4) decreased considerably. The classification of tumor stages changed during the project period, which may have contributed to an artificial decrease of the stages with a poor prognosis. Nevertheless, the results are in agreement with the observed decrease of melanoma mortality in the screening region.

Entities:  

Mesh:

Year:  2014        PMID: 24357176     DOI: 10.1007/s00103-013-1876-1

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  8 in total

1.  [Screening for colorectal, skin, breast and prostate cancer. Essential knowledge for counseling].

Authors:  J Hübner; M R Noftz; M Schnoor; A Katalinic
Journal:  Internist (Berl)       Date:  2014-10       Impact factor: 0.743

2.  [Perception of statutory skin cancer screening in the general population : Current findings on participation, knowledge and evaluation].

Authors:  L Eissing; I Schäfer; K Strömer; R Kaufmann; A Enk; M Reusch; M Augustin
Journal:  Hautarzt       Date:  2017-05       Impact factor: 0.751

3.  Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013.

Authors:  Alexander Katalinic; Nora Eisemann; Annika Waldmann
Journal:  Dtsch Arztebl Int       Date:  2015-09-18       Impact factor: 5.594

4.  One-year follow-up healthcare costs of patients diagnosed with skin cancer in Germany: a claims data analysis.

Authors:  Christian Speckemeier; Kathrin Pahmeier; Pietro Trocchi; Katrin Schuldt; Hildegard Lax; Michael Nonnemacher; Patrik Dröge; Andreas Stang; Jürgen Wasem; Silke Neusser
Journal:  BMC Health Serv Res       Date:  2022-06-11       Impact factor: 2.908

5.  The role of skin self-examination at the Swiss skin cancer day.

Authors:  Nina Badertscher; Muriel Meier; Thomas Rosemann; Ralph Braun; Antonio Cozzio; Brigitte Tag; Michel Wensing; Ryan Tandjung
Journal:  BMC Health Serv Res       Date:  2014-11-19       Impact factor: 2.655

6.  Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma.

Authors:  J Hübner; A Waldmann; A C Geller; M A Weinstock; N Eisemann; M Noftz; S Bertram; S Nolte; B Volkmer; R Greinert; E Breitbart; A Katalinic
Journal:  Br J Cancer       Date:  2016-11-29       Impact factor: 7.640

7.  Increasing Participation Rates in Germany's Skin Cancer Screening Program (HELIOS): Protocol for a Mixed Methods Study.

Authors:  Theresa Steeb; Markus V Heppt; Michael Erdmann; Anja Wessely; Stefanie J Klug; Carola Berking
Journal:  JMIR Res Protoc       Date:  2021-12-13

8.  Incidence Trends and Survival Prediction of Malignant Skin Cancer: A SEER-Based Study.

Authors:  Sirong Zhu; Chao Sun; Longjiang Zhang; Xiaoan Du; Xiaodong Tan; Shuzhen Peng
Journal:  Int J Gen Med       Date:  2022-03-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.